Citrullinated vimentin was sufficient to promote fibroblast activation in vitro and elicit profibrotic cytokine production and lung fibrosis in vivo, indicating that the PAD enzymes are a promising target to attenuate lung fibrosis. This evidence concerns the gene VIM and pulmonary fibrosis.